NLM Logo

tremelimumab MeSH Supplementary Concept Data 2023


MeSH Supplementary
tremelimumab
Unique ID
C520704
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C520704
Entry Term(s)
CP 675
CP 675206
CP-675
CP-675,206
CP-675206
CP675 cpd
CP675206
ticilimumab
Pharm Action
Antineoplastic Agents
Registry Number
QEN1X95CIX
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
213
Note
a fully human anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for immunotherapy of metastatic melanoma
Source
Am J Ophthalmol 2007 Jun;143(6):958-969
Date of Entry
2007/06/27
Revision Date
2019/11/01
tremelimumab Preferred
ticilimumab Narrower
CP 675 Narrower
CP-675,206 Narrower
page delivered in 0.005s